Vitexin reduces epilepsy after hypoxic ischemia in the neonatal brain via inhibition of NKCC1.
Vitexin reduces epilepsy after hypoxic ischemia in the neonatal brain via inhibition of NKCC1.
复制标题
牡荆素通过抑制 NKCC1 减少新生儿大脑缺氧缺血后的癫痫
DOI:
10.1186/s12974-018-1221-6
复制
发表时间:
2018-06-20
影响因子:
9.3
通讯作者:
Peng BW
中科院分区:
文献类型:
--
作者:
Luo WD;Min JW;Huang WX;Wang X;Peng YY;Han S;Yin J;Liu WH;He XH;Peng BW
BackgroundNeonatal hypoxic-ischemic brain damage, characterized by tissue loss and neurologic dysfunction, is a leading cause of mortality and a devastating disease of the central nervous system. We have previously shown that vitexin has been attributed various medicinal properties and has been demonstrated to have neuroprotective roles in neonatal brain injury models. In the present study, we continued to reinforce and validate the basic understanding of vitexin (45 mg/kg) as a potential treatment for epilepsy and explored its possible underlying mechanisms.MethodsP7 Sprague-Dawley (SD) rats that underwent right common carotid artery ligation and rat brain microvascular endothelial cells (RBMECs) were used for the assessment of Na+-K+-Cl−co-transporter1 (NKCC1) expression, BBB permeability, cytokine expression, and neutrophil infiltration by western blot, q-PCR, flow cytometry (FCM), and immunofluorescence respectively. Furthermore, brain electrical activity in freely moving rats was recorded by electroencephalography (EEG).ResultsOur data showed that NKCC1 expression was attenuated in vitexin-treated rats compared to the expression in the HI group in vivo. Oxygen glucose deprivation/reoxygenation (OGD) was performed on RBMECs to explore the role of NKCC1 and F-actin in cytoskeleton formation with confocal microscopy,N-(ethoxycarbonylmethyl)-6-methoxyquinolinium bromide, and FCM. Concomitantly, treatment with vitexin effectively alleviated OGD-induced NKCC1 expression, which downregulated F-actin expression in RBMECs. In addition, vitexin significantly ameliorated BBB leakage and rescued the expression of tight junction-related protein ZO-1. Furthermore, inflammatory cytokine and neutrophil infiltration were concurrently and progressively downregulated with decreasing BBB permeability in rats. Vitexin also significantly suppressed brain electrical activity in neonatal rats.ConclusionsTaken together, these results confirmed that vitexin effectively alleviates epilepsy susceptibility through inhibition of inflammation along with improved BBB integrity. Our study provides a strong rationale for the further development of vitexin as a promising therapeutic candidate treatment for epilepsy in the immature brain.
登录
查看更多内容
影响因子:
3.7
作者:
Cleary RT;Sun H;Huynh T;Manning SM;Li Y;Rotenberg A;Talos DM;Kahle KT;Jackson M;Rakhade SN;Berry G;Jensen FE
通讯作者:
Jensen FE
影响因子:
--
作者:
Diniz TC;Silva JC;de Lima-Saraiva SR;Ribeiro FP;Pacheco AG;de Freitas RM;Quintans-Júnior LJ;Quintans Jde S;Mendes RL;Almeida JR
通讯作者:
Almeida JR
影响因子:
82.9
作者:
通讯作者:
--
影响因子:
168.9
作者:
Gluckman, PD;Wyatt, JS;Gunn, AJ
通讯作者:
Gunn, AJ
影响因子:
9.8
作者:
Garzon-Muvdi T;Schiapparelli P;ap Rhys C;Guerrero-Cazares H;Smith C;Kim DH;Kone L;Farber H;Lee DY;An SS;Levchenko A;Quiñones-Hinojosa A
通讯作者:
Quiñones-Hinojosa A